A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/1992
12/23/1992	EP0518930A1 Cyclodextrin compositions and methods for pharmaceutical and industrial applications
12/23/1992	EP0518872A1 Topical formulation of cyclosporine
12/23/1992	EP0460080B1 Orally administerable calcium supplement for cattle
12/23/1992	EP0377613B1 Conjugates of superoxide dismutase
12/23/1992	CN1019544B Pharmaceutical composition for piperidinoalkanol derivatives
12/23/1992	CA2524168A1 Oral-administration forms of a medicament containing pantoprazole
12/23/1992	CA2111465A1 Amino acid derivative and bromoacetyl modified peptides
12/23/1992	CA2111003A1 Non-chlorofluorocarbon aerosol formulations
12/23/1992	CA2110487A1 Methods for providing localized therapeutic heat to biological tissues and fluids using gas filled liposomes
12/22/1992	US5173488 Stable injectable pharmaceutical formulation for folic acid and leucovorin salts and method
12/22/1992	US5173304 Agents for the treatment of severe pain and preparation of said agents
12/22/1992	US5173298 Nonaqueous fluorinated drug delivery vehicle suspensions
12/22/1992	US5173293 Anti-T-cell antibodies as adjuvants
12/22/1992	US5173291 Dried hydrophobic film of addition polymer complexed with iodine; surgery; bandages; sterilization of skin
12/22/1992	US5173287 Carboxylic acid compositions
12/22/1992	CA1311687C Dosage form for delivering diltiazem
12/22/1992	CA1311686C Controlled release bioerodible drug delivery system
12/20/1992	WO1992022310A1 Asialoglycoprotein-conjugated medicinal agent
12/20/1992	CA2089881A1 Asialoglycoprotein-conjugated medicinal agent
12/19/1992	CA2071141A1 Megestrol acetate formulation
12/18/1992	WO1992022201A1 Process for producing magnetically responsive polymer particles and application thereof
12/17/1992	DE4139616A1 Dispersionen aus salzen von acrylsaeurepolymeren Dispersions of salts of acrylsaeurepolymeren
12/16/1992	EP0518697A2 Collagen film for sustained delivery of proteins
12/16/1992	EP0518601A1 Non-chlorofluorocarbon aerosol formulations
12/16/1992	EP0518600A1 Non-chlorofluorocarbon aerosol formulations
12/16/1992	EP0518263A1 Micropellets and a process for their manufacture
12/16/1992	EP0517740A1 Low molecular weight carbohydrates as additives to stabilize metal oxide compositions.
12/16/1992	CN1066979A Preparing method of antibiotics for burn wound
12/15/1992	WO1992022304A1 Collagen film drug delivery for proteins
12/15/1992	US5171812 Polyanhydrides of oligomerized unsaturated aliphatic acids
12/15/1992	US5171737 Emulsions
12/15/1992	US5171666 Monoclonal antibodies reactive with a cell-surface gylcoprotein expressed on human carcinomas
12/15/1992	US5171665 Monoclonal antibody to novel antigen associated with human tumors
12/15/1992	US5171582 Placing sealed plastic container of prilled iodine in distilled water to produce pure aqueous solution
12/15/1992	US5171579 Formulations of blood clot-polymer matrix for delivery of osteogenic proteins
12/15/1992	US5171578 Administering streptavidin-coupled liposomes
12/15/1992	US5171567 Method for the treatment of atll and the inhalant for the same
12/15/1992	US5171563 Cleavable linkers for the reduction of non-target organ retention of immunoconjugates
12/15/1992	US5171264 Immobilized polyethylene oxide star molecules for bioapplications
12/15/1992	US5171217 Method for delivery of smooth muscle cell inhibitors
12/15/1992	CA2089487A1 Collagen film drug delivery for proteins
12/15/1992	CA1311475C Process for preparing partial polyol fatty acid esters
12/15/1992	CA1311474C Process for preparing polyol fatty acid polyesters
12/15/1992	CA1311473C Fatty acid esters of sugars and sugar alcohols
12/15/1992	CA1311419C Utilization of otilonium bromide for topical application in the gastrointestinal tract and pharmaceutical formulations appropriate for such use
12/15/1992	CA1311416C Composition comprising an oxygenated cholesterol and use thereof for topical treatment of diseases
12/10/1992	WO1992021670A1 New biotenside ester and phosphatide with vitamin d and vitamin e compounds; their preparation and transformation into spontaneously dispersible concentrates and their use for treating tumors
12/10/1992	WO1992021382A1 Improvements in or relating to contrast agents
12/10/1992	WO1992021381A1 Preparation of protein/polyalkylene glycol conjugates
12/10/1992	WO1992021354A1 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
12/10/1992	WO1992021353A1 Compositions and delivery systems for transdermal administration of neutral oligomers
12/10/1992	WO1992021351A1 Polydeoxyribonucleic acid based pharmaceutical compounds and method for preparing same
12/10/1992	WO1992021338A1 Medetomidine preparations for transdermal administration
12/10/1992	WO1992021329A1 Biodegradable particulate vector and method of synthesis
12/10/1992	WO1992021324A1 Pharmaceutical enema preparation
12/10/1992	WO1992021318A1 N-acyl derivatives of amino acid mixtures derived from cereal protein hydrolysates and applications thereof
12/10/1992	WO1992018165A3 Improved fluorocarbon contrast media for use with MRI and radiographic imaging
12/10/1992	WO1992017184A3 Bioactive topical siloxane compositions having enhanced performance and safety
12/10/1992	WO1992009690A3 Enrichment method for variant proteins with altered binding properties
12/10/1992	CA2110593A1 N-acyl derivatives of amino acids mixtures obtained from grain protein hydrolysates and their applications
12/10/1992	CA2110590A1 Improvements in or relating to contrast agents
12/10/1992	CA2110040A1 Compositions and delivery systems for transdermal administration of neutral oligomers
12/10/1992	CA2088759A1 Biodegradable particulate carrier and generation process therefor
12/09/1992	EP0517565A2 Process for the preparation of microspheres containing biologically active components
12/09/1992	EP0517274A1 Pharmaceutical enema
12/09/1992	EP0517211A1 Physiologically active polypeptide containing pharmaceutical composition
12/09/1992	EP0517182A1 Hepatocyte-growth agent
12/09/1992	EP0517160A1 Extended-release ophthalmic preparations
12/09/1992	EP0516953A1 Conjugates of liposomes or micro-beads and antibodies specific for T lymphocytes
12/09/1992	EP0516704A1 Novel insulin compositions.
12/09/1992	EP0516685A1 Artificial tears
12/09/1992	EP0424516B1 Very low temperature casting of controlled release microspheres
12/08/1992	WO1992021325A1 Oral composition based on an antibiotic material and clay
12/08/1992	US5169967 Aluminum magnesium hydroxy fatty acid compounds and thermostable lipogels including same
12/08/1992	US5169934 Intracellularly cleavable compounds
12/08/1992	US5169933 Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
12/08/1992	US5169864 Sterile aqueous formulation of histamine H2 antagonist for antiulcer; storage stability
12/08/1992	US5169847 Aqueous solutions of piroxicam, sodium glycinecarboxylate, additives, for eye drops
12/08/1992	US5169842 Oligophosphates with an antiviral action
12/08/1992	US5169641 Hydrolytically degradable polyester/silicon co-crosslinked matrices
12/08/1992	US5169639 Controlled release verapamil tablets
12/08/1992	US5169638 Buoyant controlled release powder formulation
12/08/1992	US5169627 Having resistance to degradation by intestinal enzymes while retaining immunological activity
12/08/1992	CA2088983A1 Therapeutic composition for gastrointestinal system inflammations
12/06/1992	WO1992021330A1 Particulate vector having selective tropism, method of preparation and pharmaceutical composition
12/06/1992	CA2088910A1 Particulate vector with selective tropism, process for the preparation thereof and pharmaceutical composition
12/05/1992	CA2043864A1 Direct compression cyclophosphamide tablet
12/04/1992	WO1992021384A1 X-ray contrast agent
12/04/1992	CA2070263A1 Hepatocyte-growth agent
12/03/1992	DE4117784A1 Herstellung von protein-polyalkylenglykolkonjugaten Preparation of protein-polyalkylenglykolkonjugaten
12/02/1992	EP0516252A2 Monocrystalline particles of iron-oxide for application in medical diagnosis and therapy
12/02/1992	EP0516194A2 Pharmaceutical compositions containing cationic surfactants
12/02/1992	EP0516190A2 Monoclonal antibodies, process for preparing them and their use
12/02/1992	EP0516141A1 Pharmaceutical controlled-release composition with bioadhesive properties
12/02/1992	EP0516026A1 Hydrogel and method of producing same
12/02/1992	EP0515949A2 Method for the production of polyethylene oxide with an intermediate molecular weight
12/02/1992	EP0515510A1 Hydroquinone amino-acid esters, method of preparation, and pharmaceutical or cosmetic compositions containing them.
12/02/1992	EP0515460A1 Docosahexaenoic acid, methods for its production and compounds containing the same
12/02/1992	EP0515395A1 Sapphyrins, derivatives and synthesis
12/02/1992	EP0357724B1 Stabilized heparin solution

1 ... 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 1624 ... 1712